FDA panel backs limited use of alpha hydroxy acids in cosmetics
FDA advisers approve safe use of alpha hydroxy acids in OTC products up to 10 percent with sunscreen guidance. Salons may offer chemical peels up to 30 percent with daily sun protection. FDA to study long term effects and sun sensitivity while noting a broader safety question about aging skin and cancer risk.
MENTIONED IN THIS ARTICLE
Bluey Leave
Heron Cosmetics
Food and Drug Administration
FDA
John Bailey
Massachusetts General Hospital
Long term effects of diet drugs studied
Obese individuals may need ongoing use of diet medications to lose weight and maintain it, but safety of long term use remains uncertain. A JAMA review of 20 studies finds limited evidence on effects beyond a year and recommends indefinite use only for those severely overweight or at high medical risk after failed past attempts.
MENTIONED IN THIS ARTICLE
Chicago
Susan Zelitch Yanovski
Journal of the
American Medical Association
National Task Force On Prevention and Treatment
Yanovski
Eating Disorders Clinic
National
Armiua
Safety of ICSI infertility treatment backed by study
A New York study confirms intracytoplasmic sperm injection raises pregnancy rates similar to standard IVF and shows birth defect rates under 3 percent. The research, involving 751 couples treated for male infertility at a single center, found no increased risk overall, with most abnormalities in multiple pregnancies.
MENTIONED IN THIS ARTICLE
Cpsc Ags
Belgium
New York State
Journal of the American Medical Association
Zev Rosenwaks
Center For
New York Hospital-Cornell Medical Center
New York City
12-step program remains most effective in alcoholism treatment
A government funded eight year study of 1,726 patients finds the 12-step AA model remains most effective, especially for those with strong spiritual beliefs. Three programs were tested including cognitive behavioral therapy and motivation based approaches, with all groups improving though the 12-step group showing higher abstinence. The findings challenge the need for patient treatment matching.
MENTIONED IN THIS ARTICLE
Enoch Gordis
National Institute On Alcohol Abuse and
Alcoholism
Lipitor Wins FDA Nod to Cut LDL Cholesterol
The Food and Drug Administration approved Lipitor to reduce LDL cholesterol by about 40 percent in most patients and up to 40 percent for fats. It also lowers triglycerides by 20 to 40 percent. Lipitor is the first drug to treat a rare inherited condition causing sharply rising cholesterol in children as young as nine, with potential teen heart attacks. Lipitor will be provided at no charge to the affected patients.
MENTIONED IN THIS ARTICLE
Lipitor
Also Mentioned on This Page
Smootsies
Black
A.iz Claiborne
Francis Scott Key
Washington
Alcoholics Anonymous
Fashion Adwee
Pearle
David Yoffe
Francis Scott Key Mall
Frederick
Stan
Pero Vemeiniveen
Bas
IPR Cie
CURA